214
E. Dardennes et al. / Tetrahedron: Asymmetry 21 (2010) 208–215
26.8, 27.8, 28.1, 38.0, 49.1, 66.0, 74.6, 75.1, 75.5, 81.6, 104.9, 108.7,
110.6, 114.0, 119.8, 120.0, 122.1, 123.5, 127.1, 127.7, 127.8, 128.3,
135.2, 138.2, 165.1, 166.0 ppm; MS (EI) m/z (%) 660 (M+Å+Na, 43),
638 (4), 580 (100), 558 (23), 522 (15), 451 (8). HRMS calcd for
C35H47NO8SiNa 660.2969, found 660.2958. Anal. Calcd for
C35H47NO8Si: C, 65.91; H, 7.43; N, 2.20. Found: C, 65.70; H, 7.39; N,
2.22. epi-4g: Mp: 141–142 °C (cyclohexane–ethyl acetate);
4.10. (3S,4S,5S)-5-[20,20-Bis(ethylsulfanyl)-(10R)-10-
hydroxyethyl]-4-(1H-indol-3-yl)-2-oxo-tetrahydrofuran-3-
carboxylic acid 5e
To a solution of 4e (1.05 g, 2.17 mmol) in tetrahydrofuran
(10 mL) was added an aqueous 4 M solution of HCl (5 mL). After
two days stirring at room temperature the solvent was removed,
the residue was dissolved in dichloromethane (10 mL) and washed
with 10% K2CO3 solution (3 ꢀ 5 mL). The aqueous phase was acid-
ified with solid citric acid and extracted with dichloromethane
(3 ꢀ 10 mL). The combined organic phases were dried (MgSO4), fil-
tered and evaporated giving 5e (666 mg, 75%), as a white solid. Mp:
½
a 2D2
ꢂ
¼ ꢁ138:4 (c 0.42, CHCl3); UV (MeOH) k 291, 281, 274, 223,
213 nm; IR (KBr) 3427, 2978, 2943, 2881, 1775, 1740, 1458,
1379, 1326, 1296, 1256, 1097, 1067, 1005, 891, 868, 833 cmꢁ1 1H
m
;
NMR (CDCl3) d ꢁ0.86 (s, 3H), ꢁ0.17 (s, 3H), 0.40 (s, 9H), 1.19 (s,
3H), 1.27 (s, 3H), 1.34 (s, 3H), 1.45 (s, 3H), 3.93–4.03 (m, 3H), 4.19
(dd, 1H, J = 7.1, 6.3 Hz), 4.59–4.71 (m, 3H), 4.78 (d, 1H, J = 2.7 Hz),
4.99 (dd, 1H, J = 10.6, 4.2 Hz), 6.97–7.32 (m, 9H), 7.68–7.70 (m,
1H), 8.05 (br s, 1H) ppm; 13C NMR (CDCl3) d ꢁ6.0, ꢁ4.9, 17.5, 25.3,
25.4, 26.2, 26.7, 28.0, 38.1, 49.1, 65.0, 72.0, 74.1, 74.8, 81.7, 104.5,
107.8, 110.4, 114.6, 119.4, 119.8, 121.9, 122.8, 127.9, 128.4, 128.5,
135.0, 137.7, 164.9, 166.2 ppm; MS (EI) m/z (%) 660 (M+Å+Na, 32),
638 (7), 580 (100), 558 (10). Anal. Calcd for C35H47NO8Si: C, 65.91;
H, 7.43; N, 2.20. Found: C, 65.48; H, 7.59; N, 2.02.
71–72 °C; ½a 2D4
ꢂ
¼ þ189:5 (c 0.4, CHCl3); UV (MeOH) kmax 290, 281,
3406, 2966, 2918, 1771, 1729, 1457, 1424,
1H
274, 220 nm; IR (KBr)
m
1376, 1338, 1314, 1262, 1233, 1148, 1100, 1009, 743 cmꢁ1
;
NMR (CDCl3) d 1.11 (t, 3H, J = 11.2 Hz), 1.21 (t, 3H, J = 7.6 Hz),
2.31–2.69 (m, 4H), 3.17 (d, 1H, J = 10.6 Hz), 3.91 (d, 1H,
J = 10.6 Hz), 4.50 (d, 1H, J = 12.8 Hz), 4.66 (dd, 1H, J = 12.8,
8.3 Hz), 5.59 (d, 1H, J = 8.3 Hz), 7.09–7.26 (m, 3H), 7.34 (d, 1H,
J = 7.9 Hz), 7.54 (d, 1H, J = 7.6 Hz), 8.25 (br s, 1H) ppm; 13C NMR
(CDCl3) d 14.3, 25.4, 26.9, 40.1, 50.5, 55.5, 70.4, 79.2, 109.1,
111.6, 118.3, 120.1, 122.5, 122.6, 126.5, 136.2, 172.4 ppm; MS
(EI) m/z (%) 399 (M+Å+Na, 18), 378 (25), 377 (23), 333 (100), 218
(53). Anal. Calcd for C19H23NO5S2ꢃ0.5H2O: C, 54.53; H, 5.78; N,
3.35. Found: C, 54.87; H, 5.70; N, 3.49.
4.8. 5-{(S)-[(3a0R,50R,60S,6a0R)-60-Benzyloxy-20,20-dimethyl-
dihydro-5H-furo[3,2-d][1,3]dioxol-50-yl](1H-indol-3-
yl)methyl}-2,2-dimethyl-1,3-dioxane-4,6-dione 4i
Isolated by crystallisation from cyclohexane–ethyl acetate (4:1).
4.11. (3S,4S,5S)-4-(1H-Indol-3-yl)-2-oxo-5-[(10S,20S)-10,20,30-
Mp: 157 °C (cyclohexane–ethyl acetate); ½a D24
¼ þ22:2 (c 0.4,
ꢂ
trihydroxypropan-10-yl]-tetrahydrofuran-3-carboxylic acid 5f
CHCl3); UV (MeOH) kmax 290, 280, 272, 221, 198 nm; IR (KBr)
m
3366, 3056, 2982, 2923, 2864, 1775, 1746, 1455, 1381, 1352,
A solution of 4f (142 mg, 0.23 mmol) in ethyl acetate (10 mL)
was hydrogenated over 10% PdC (50 mg) for 24 h. The catalyst
was removed by filtration on a CeliteÒ pad, the filtrate was evapo-
rated and the residue was purified by chromatography (elution:
ethyl acetate–methanol 8:2 and some drops of acetic acid) to af-
1289, 1211, 1164, 1123, 1097, 1068, 1046, 950, 887, 858, 773,
740 cmꢁ1 1H NMR (CDCl3) d 0.90 (s, 3H), 1.33 (s, 6H), 1.56 (s,
;
3H), 3.35 (d, 1H, J = 3.0 Hz), 4.18 (d, 1H, J = 3.0 Hz), 4.47 (d, 1H,
J = 12.0 Hz), 4.54 (dd, 1H, J = 10.6, 3.0 Hz), 4.78 (d, 1H, J = 4.0 Hz),
4.88 (d, 1H, J = 12.0 Hz), 5.32 (dd, 1H, J = 10.6, 3.0 Hz), 5.91 (d,
1H, J = 4.0 Hz), 7.04–7.47 (m, 9H), 7.73–7.78 (m, 1H); 8.22 (br s,
1H) ppm; 13C NMR(CDCl3) d 26.5, 26.9, 27.9, 28.1, 35.8, 48.3,
71.0, 80.4, 81.2, 81.9, 104.8, 105.2, 110.9, 111.7, 112.1, 119.8,
119.9, 122.1, 123.4, 126.7, 128.5, 128.6, 128.8, 135.6, 136.8,
165.1, 169.9 ppm; MS (EI) m/z (%) 521 (M+Å, 65), 494 (15), 463
(8), 419 (21), 377 (23), 346 (15), 329 (28); HRMS calcd for
C29H31NO8 521.2050, found 521.2056.
ford 5f (73 mg, 95%), as
¼ þ139:3 (c 0.22, acetone); UV (MeOH) kmax 291, 282, 275,
223, 207 nm; IR (KBr) 3401, 2925, 1740, 1603, 1384, 1344,
1229, 1181, 1089, 1053, 1005, 745 cmꢁ1 1H NMR (acetone-d6) d
a white solid. Mp: 192–193 °C;
½ ꢂ
a 2D4
m
;
3.41 (d, 1H, J = 9.1 Hz), 3.51–3.67 (m, 3H), 4.48 (d, 1H,
J = 12.9 Hz), 4.72 (dd, 1H, J = 12.9, 8.7 Hz), 5.45 (d, 1H, J = 8.7 Hz),
7.02–7.18 (m, 2H), 7.39–7.45 (m, 2H), 7.70 (d, 1H, J = 7.8 Hz),
10.28 (br s, 1H) ppm; 13C NMR (acetone-d6) d 41.3, 52.1, 64.6,
70.9, 72.1, 80.6, 110.5, 112.3, 119.4, 120.1, 122.7, 123.6, 128.2,
137.6, 170.3, 173.3 ppm; MS (EI) m/z (%) 341 (M+Å+Na, 12), 320
(11), 319 (9), 275 (100), 160 (43). Anal. Calcd for C16H17NO6: C,
60.18; H, 5.38; N, 4.39. Found: C, 59.89; H, 5.70; N, 4.49.
4.9. (3S,4S,5S)-4-(1H-Indol-3-yl)-2-oxo-5-[(10S,20S)-10,20,30-
trihydroxypropan-10-yl]-tetrahydrofuran-3-carboxylic acid
methyl ester 5d
4.12. (3S,4S,5S)-4-(1H-Indol-3-yl)-2-oxo-5-[(10R,20S)-10-tert-butyldi
methylsilyloxy-20,30-dihydroxy-20,30-di-O-isopropylidene-propan-
10-yl]-tetrahydrofuran-3-carboxylic acid 5g
To a solution of 4d (204 mg, 0.43 mmol) in methanol (2 mL) was
added a solution of methanol saturated with HCl (5 mL) at 0 °C.
After 30 min stirring at room temperature the solvent was re-
moved and the residue was purified by column chromatography
(elution: CH2Cl2–methanol 9:1) to give 5d (142 mg, 95%), as a
A solution of 4g (184 mg, 0.27 mmol) in ethyl acetate (20 mL)
was hydrogenated over 10% PdC (50 mg) for 24 h. The catalyst
was removed by filtration on a CeliteÒ pad, the filtrate was evapo-
rated to give 5g (132 mg, 100%), as a white solid. Mp: 76–80 °C;
white solid. Mp: 131–133 °C (MeOH–toluene); ½a D23
¼ þ134:6 (c
ꢂ
0.23, MeOH); UV (MeOH) kmax 290, 281, 274, 221 nm; IR (KBr)
m
3410, 2943, 1749, 1723, 1458, 1432, 1379, 1335, 1296, 1229,
1199, 1150, 1093, 1057, 1040, 1009, 996, 750 cmꢁ1 1H NMR
;
½
a 2D5
ꢂ
¼ þ70 (c 0.13, CHCl3); UV (MeOH) kmax 291, 282, 275,
(CD3OD) d 3.28 (d, 1H, J = 9.4 Hz), 3.41–3.45 (m, 1H), 3.56–3.66
(m, 5H), 4.56 (d, 1H, J = 13.1 Hz), 4.71 (dd, 1H, J = 13.1, 8.4 Hz),
5.45 (d, 1H, J = 8.4 Hz), 7.01–7.20 (m, 2H), 7.27 (s, 1H), 7.31 (d,
1H, J = 8.1 Hz), 7.56 (d, 1H, J = 7.8 Hz) ppm; 13C NMR (CD3OD) d
41.7, 52.5, 53.3, 64.4, 71.3, 72.0, 81.8, 109.9, 112.5, 119.2, 120.4,
123.0, 123.6, 128.1, 129.2, 129.9, 138.1, 170.8, 174.9 ppm; MS
(EI) m/z (%) 349 (M+Å, 45), 291 (23), 189 (100). Anal. Calcd for
C17H19NO7: C, 58.44; H, 5.48; N, 4.01. Found: C, 58.71; H, 5.56;
N, 4.30.
221 nm; IR (KBr)
m 3415, 2956, 2927, 1776, 1733, 1633, 1457,
1381, 1257, 1157, 1067, 833, 781 cmꢁ1
;
1H NMR (CDCl3) d ꢁ0.09
(s, 3H), ꢁ0.01 (s, 3H), 0.85 (s, 9H), 1.22 (s, 3H), 1.23 (s, 3H), 3.67
(dd, 1H, J = 7.5, 6.4 Hz), 3.80 (dd, 1H, J = 4.9, 4.1 Hz), 3.93–4.02
(m, 2H), 4.05 (d, 1H, J = 8.7 Hz), 4.47 (dd, 1H, J = 8.7, 7.2 Hz), 5.17
(dd, 1H, J = 7.2, 4.1 Hz), 7.10–7.25 (m, 3H), 7.40 (d, 1H, J = 8.1 Hz),
7.50 (d, 1H, J = 7.5 Hz), 8.40 (br s, 1H) ppm; 13C NMR (CDCl3) d
ꢁ3.9, ꢁ3.7, 18.4, 24.9, 25.9, 26.0, 40.1, 52.7, 66.2, 71.8, 76.0, 82.2,
109.1, 110.6, 111.7, 118.8, 120.4, 122.1, 123.0, 125.9, 136.3,
171.1, 171.6 ppm; MS (EI) m/z (%) 511 (M+Å+Na, 17), 490 (21),